Nxera Pharma Submits Marketing Authorization Application for Vamorolone in South Korea for the Treatment of Duchenne ...
Submission marks an important milestone towards bringing a new treatment option to patients with DMD in South Korea. Vamorolone has already received South Korean Orphan Drug Designation (ODD) and Global Innovative Products on Fast Track (GIFT) designation …